
CTSO
Healthcare · Medical Devices · $15.3M market cap
$4.87-0.50 (-9.3%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.90 | -0.58 | +35.6% |
| Aug 6, 2026 | After the close | -0.05 | -0.07 | -40.0% |
| May 13, 2026 | After the close | -0.05 | -0.08 | -60.0% |
| Mar 11, 2026 | Time not confirmed | -0.04 | -0.09 | -104.1% |
| Nov 13, 2025 | After the close | -0.05 | -0.05 | 0.0% |
| Aug 7, 2025 | After the close | -0.07 | -0.05 | +28.6% |
| May 14, 2025 | After the close | -0.07 | -0.02 | +71.4% |
| Mar 12, 2025 | Before the open | -0.05 | -0.14 | -162.7% |
| Nov 7, 2024 | After the close | -0.06 | -0.08 | -33.3% |
| Aug 13, 2024 | After the close | -0.10 | -0.08 | +20.0% |
| May 9, 2024 | After the close | -0.12 | -0.12 | 0.0% |
| Mar 14, 2024 | After the close | -0.14 | -0.13 | +7.1% |
| Nov 9, 2023 | After the close | -0.12 |
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and…
| -0.21 |
| -75.0% |
| Aug 1, 2023 | After the close | -0.14 | -0.14 | 0.0% |
| May 2, 2023 | After the close | -0.13 | -0.17 | -30.8% |
| Mar 9, 2023 | After the close | -0.15 | -0.01 | +93.3% |
| Nov 3, 2022 | After the close | -0.16 | -0.28 | -75.0% |
| Aug 2, 2022 | After the close | -0.12 | -0.25 | -108.3% |
| May 3, 2022 | After the close | -0.14 | -0.21 | -50.0% |
| Mar 8, 2022 | After the close | -0.13 | -0.21 | -61.5% |
| Nov 4, 2021 | After the close | -0.12 | -0.15 | -25.0% |
| Aug 3, 2021 | After the close | -0.05 | -0.11 | -120.0% |
| May 4, 2021 | After the close | -0.05 | -0.10 | -100.0% |
| Mar 9, 2021 | After the close | -0.04 | -0.01 | +75.0% |
| Nov 4, 2020 | After the close | -0.09 | -0.02 | +77.8% |
| Aug 4, 2020 | After the close | -0.09 | -0.08 | +11.1% |
| May 5, 2020 | After the close | -0.15 | -0.10 | +33.3% |
| Mar 5, 2020 | After the close | -0.16 | -0.12 | +25.0% |
| Nov 5, 2019 | After the close | -0.14 | -0.21 | -50.0% |
| Aug 6, 2019 | After the close | -0.14 | -0.11 | +21.4% |
| May 7, 2019 | After the close | -0.18 | -0.15 | +16.7% |
| Mar 7, 2019 | After the close | -0.13 | -0.17 | -30.8% |
| Nov 6, 2018 | After the close | -0.14 | -0.10 | +28.6% |
| Aug 2, 2018 | After the close | -0.13 | -0.19 | -46.2% |
| May 8, 2018 | After the close | -0.13 | -0.10 | +23.1% |
| Mar 8, 2018 | After the close | -0.09 | -0.11 | -22.2% |